Biogen Inc. (BIIB)

• Annual Data
• Quarterly Data

Biogen Inc., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders’ Equity

		Dec 31, 2018		Dec 31, 2017		Dec 31, 2016		Dec 31, 2015		Dec 31, 2014
	Current portion of notes payable
	Taxes payable
	Accounts payable
	Revenue-related reserves for discounts and allowances
	Current portion of contingent consideration obligations
	Employee compensation and benefits
	Royalties and licensing fees
	Construction in progress
	Collaboration expenses
	Accrued TECFIDERA litigation settlement charges
	Other
	Accrued expenses and other
	Current liabilities
	Notes payable, excluding current portion
	Deferred tax liability
	Other long-term liabilities
	Non-current liabilities
	Total liabilities
	Preferred stock, par value $0.001 per share
	Common stock, par value $0.0005 per share
	Additional paid-in capital
	Accumulated other comprehensive loss
	Retained earnings
	Treasury stock, at cost
	Total Biogen Inc. shareholders’ equity
	Noncontrolling interests
	Total equity
	Total liabilities and equity

Based on: 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03), 10-K (filing date: 2015-02-04).